BACKGROUND: Heller myotomy is accepted as first-line therapy for achalasia, yet for a small number of patients, symptoms persist or recur after myotomy. This study was undertaken to report our results with reoperative laparoscopic Heller myotomy for recurrent symptoms of achalasia. METHODS: We have undertaken laparoscopic Heller myotomy in 275 patients and reoperative myotomy in 12 patients for recurrent dysphagia, of which three had their initial myotomy undertaken by us. For each, studies prior to reoperative Heller myotomy documented a nonrelaxing lower esophageal sphincter without stricture. Patients scored symptoms before and after reoperative myotomy. RESULTS: Before reoperative myotomy, 75% underwent dilation and 42% underwent Botox injection. Ten of twelve reoperative myotomies were undertaken and completed laparoscopically. Median follow-up is 24.1 months (29.0 months + 25.89). Symptom frequency and severity scores improved significantly after reoperative myotomy. Frequency of vomiting and frequency and severity of heartburn were improved after reoperative myotomy, but not to a significant extent. However, they were not particularly notable prior to surgery, compared to obstructive symptoms, such as dysphagia. Excellent or good outcomes were reported in 73%, and notably, 91% stated that they would have the operation again after having been through the process firsthand and knowing their outcomes. CONCLUSION: Patient outcomes promote the application of reoperative Heller myotomy for recurrent or persistent symptoms of achalasia following Heller myotomy.
BACKGROUND: Heller myotomy is accepted as first-line therapy for achalasia, yet for a small number of patients, symptoms persist or recur after myotomy. This study was undertaken to report our results with reoperative laparoscopic Heller myotomy for recurrent symptoms of achalasia. METHODS: We have undertaken laparoscopic Heller myotomy in 275 patients and reoperative myotomy in 12 patients for recurrent dysphagia, of which three had their initial myotomy undertaken by us. For each, studies prior to reoperative Heller myotomy documented a nonrelaxing lower esophageal sphincter without stricture. Patients scored symptoms before and after reoperative myotomy. RESULTS: Before reoperative myotomy, 75% underwent dilation and 42% underwent Botox injection. Ten of twelve reoperative myotomies were undertaken and completed laparoscopically. Median follow-up is 24.1 months (29.0 months + 25.89). Symptom frequency and severity scores improved significantly after reoperative myotomy. Frequency of vomiting and frequency and severity of heartburn were improved after reoperative myotomy, but not to a significant extent. However, they were not particularly notable prior to surgery, compared to obstructive symptoms, such as dysphagia. Excellent or good outcomes were reported in 73%, and notably, 91% stated that they would have the operation again after having been through the process firsthand and knowing their outcomes. CONCLUSION: Patient outcomes promote the application of reoperative Heller myotomy for recurrent or persistent symptoms of achalasia following Heller myotomy.
Authors: M F Vaezi; J E Richter; C M Wilcox; P L Schroeder; S Birgisson; R L Slaughter; R E Koehler; M E Baker Journal: Gut Date: 1999-02 Impact factor: 23.059
Authors: G Zaninotto; M Costantini; D Molena; F Buin; A Carta; L Nicoletti; E Ancona Journal: J Gastrointest Surg Date: 2000 May-Jun Impact factor: 3.452
Authors: Thomas N Robinson; Carlos A Galvani; Sanjoy K Dutta; Maria V Gorodner; Marco G Patti Journal: J Laparoendosc Adv Surg Tech A Date: 2003-12 Impact factor: 1.878
Authors: Benjamin R Veenstra; Ross F Goldberg; Steven P Bowers; Mathew Thomas; Ronald A Hinder; C Daniel Smith Journal: Surg Endosc Date: 2015-08-15 Impact factor: 4.584
Authors: Arzu Oezcelik; Jeffrey A Hagen; James M Halls; Jessica M Leers; Emmanuele Abate; Shahin Ayazi; Joerg Zehetner; Steven R DeMeester; Farzaneh Banki; John C Lipham; Tom R DeMeester Journal: J Gastrointest Surg Date: 2008-10-24 Impact factor: 3.452
Authors: Sharona Ross; Desiree Villadolid; Sam Al-Saadi; Robert Boyle; Sarah M Cowgill; Alexander Rosemurgy Journal: J Gastrointest Surg Date: 2008-10-15 Impact factor: 3.452